Dear Dr. Roach: I just discontinued using metoprolol succinate extended release (ER) at a dosage of 6.25 mg. My heart rate is normally in the 70-80s, and my blood pressure is normal. My doctor ...

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ®) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1 ** Oral semaglutide 25 mg ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

Aficamten, a cardiac myosin inhibitor, outperformed metoprolol in treating symptomatic obstructive hypertrophic cardiomyopathy in the MAPLE-HCM trial. The trial demonstrated aficamten's superior ...

TOKYO, Nov 20, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has launched fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor "TASFYGO Tablets 35mg" ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes as are the investigational 50-mg oral dose and the injectable 2.4-mg dose ...

A 36-year-old Black female was referred to the University Hospital for cardiologic evaluation due to previous diagnosis of DCM/PPCM associated with family history of sudden cardiac death (SCD). She ...

TOKYO, Sept 24, 2024 - (JCN Newswire) - - Anticancer Agent "Tasfygo(R) Tablets 35mg" (Tasurgratinib Succinate) Approved in Japan for Biliary Tract Cancer with FGFR2 Gene Fusions or Rearrangements ...

Division of Advanced Heart Failure and Transplant Cardiology, Mayo Clinic, Jacksonville, FL, United States Background: Mechanical circulatory support (MCS), temporary or durable, is essential in ...

aDepartment of Medicine, Division of Endocrinology, Diabetes & Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA bDepartment of Endocrinology and Diabetes, University ...